Yoh Matsuoka

14PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 06, 2026
Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.

|Jan 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study.

Takuma Kato, Akira Yokomizo, Ryuji Matsumoto

|Jun 17, 2025
Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study.

Yosuke Yasuda, Noboru Numao, Shunya Matsumoto

|Apr 08, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study.

Leandro Blas, Masaki Shiota, Takuma Kato

|Mar 10, 2025
Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan.

Shugo Yajima, Shinro Hata, Naoya Masumori

|Feb 27, 2025
Editorial Comment to "Combining Percentage Prostate-Specific Antigen Reduction and Multiparametric Magnetic Resonance Imaging to Reduce Unnecessary Biopsy After Focal Therapy With High-Intensity Focused Ultrasound for Prostate Cancer".

Yoh Matsuoka

Pageof 3

Frequent Collaborators

7 joint publications

Hajime Tanaka

5 joint publications

Yasuhisa Fujii

3 joint publications

Soichiro Yoshida

3 joint publications

Yuki Arita